¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå ±Ô¸ð Á¶»ç : À¯Çüº°, Ä¡·áº°, Åõ¿© °æ·Îº°, ÃÖÁ¾ »ç¿ëÀÚº°, À¯Åë ä³Îº°, Áö¿ªº° ¿¹Ãø(2022-2032³â)
Global Endometriosis Market Size Study by Type, by Treatment, by Route of Administration, by End-Users, by Distribution Channel and Regional Forecasts 2022-2032
»óǰÄÚµå : 1529432
¸®¼­Ä¡»ç : Bizwit Research & Consulting LLP
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 285 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,950 £Ü 6,767,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,544,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è Àڱ󻸷Áõ ½ÃÀåÀº 2023³â ¾à 12¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024-2032³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 5.0% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àڱ󻸷ÁõÀº Àڱà ³»¸·À̶ó´Â Àڱà ³»¸·°ú À¯»çÇÑ Á¶Á÷ÀÌ Àڱà ¹Û¿¡¼­ Áõ½ÄÇÏ´Â ¸¸¼º ÁúȯÀÔ´Ï´Ù. ÀÌ ºñÁ¤»óÀûÀÎ Áõ½ÄÀº ³­¼Ò, ³­°ü, ÀÚ±Ã¿Ü Ç¥¸é ¹× ±âŸ °ñ¹Ý ³» Àå±â¿¡ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. Àڱ󻸷ÁõÀº ƯÈ÷ ¿ù°æ ½Ã Å« ÅëÁõÀ» À¯¹ßÇÏ°í ºÒÀÓÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. Àڱ󻸷Áõ ½ÃÀåÀº ¿©¼º °Ç°­ ¹®Á¦¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÌ ÁúȯÀÇ °íÅëÀ» ¿ÏÈ­Çϱâ À§ÇØ °í¾ÈµÈ Çõ½ÅÀûÀÎ Ä¡·á¹ýÀÌ µµÀԵǸ鼭 Å« º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. Àڱ󻸷Áõ¿¡ ´ëÇÑ Àü ¼¼°è ¿©¼ºµéÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í °Ç°­ ¹®Á¦¿¡ ´ëÇÑ ¸ñ¼Ò¸®°¡ ³ô¾ÆÁö¸é¼­ Àڱ󻸷Áõ ½ÃÀåÀº ¼öÀͼºÀÌ ³ô°í Áß¿äÇÑ ½ÃÀåÀ¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

Àڱ󻸷Áõ À¯º´·ü Áõ°¡·Î ȯÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ¿¬±¸ °³¹ßÀÇ ÃÊÁ¡ÀÌ Ä¡·á¹ý °³¼±À¸·Î ¿Å°Ü°¡°í ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ Á¤ºÎÀÇ ÅõÀÚ´Â Àڱ󻸷Áõ Ä¡·á¸¦ À§ÇÑ ¾à¹° ¹× Áø´Ü Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. °í°¡ÀÇ È£¸£¸ó ±â¹Ý Ä¡·áÁ¦°¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, °¢ ȸ»ç´Â ȯÀÚµéÀÇ ºñ¿ë ºÎ´ãÀ» ÁÙÀ̱â À§ÇØ È¯ÀÚ Áö¿ø ÇÁ·Î±×·¥À» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ°í ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª Àڱ󻸷Áõ¿¡ ´ëÇÑ ºñħ½ÀÀû Áø´Ü °Ë»ç°¡ ¾ø±â ¶§¹®¿¡ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¶±â ¹ß°ß¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖÀ½¿¡µµ ºÒ±¸ÇÏ°í ºñħ½ÀÀû Áø´Ü ÀýÂ÷¿¡ ´ëÇÑ µÎ·Á¿òµµ µµÀü°úÁ¦·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»ç¿¡¼­ °ËÅäÇÑ ÁÖ¿ä Áö¿ªÀº ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä« ¹× ±âŸ ¼¼°è ±âŸ Áö¿ªÀÔ´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ´Ù¼öÀÇ Á¦³×¸¯ Á¦Á¶¾÷ü°¡ Á¸ÀçÇÏ°í °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ¾ÆÅÂÁö¿ªÀº »ý¸í°úÇÐ »ê¾÷¿¡¼­ Å« ±âȸ¸¦ Á¦°øÇϰí ÀÖÀ¸¸ç, Àεµ¿Í Çѱ¹°ú °°Àº ±¹°¡µéÀÌ ¹ÙÀÌ¿ÀÀǾàǰ Çõ½ÅÀÇ ÁÖ¿ä °ÅÁ¡À¸·Î ÀÚ¸®¸Å±èÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. »ý¸íÀ» À§ÇùÇÏ´Â Áúº´ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÀǾàǰ ¿¬±¸°³¹ßÀÇ Á߿伺ÀÌ °­Á¶µÇ°í ÀÖÀ¸¸ç, ÀÌ´Â °ü·Ã Áø´Ü ¹× Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â Àß È®¸³µÈ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, Áúȯº° Ä¡·á¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä, ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó¸¦ ¹ÙÅÁÀ¸·Î °¡Àå ºü¸¥ ½ÃÀå ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ±× µÚ¸¦ À̾î À¯·´ÀÌ Àü ¼¼°èÀûÀ¸·Î ÆÇ¸ÅµÇ´Â ÀǾàǰ Á¦Á¶¾÷üÀÇ Á¸Àç¿Í Àα¸ Áõ°¡·Î ÀÎÇØ ±Ù¼ÒÇÑ Â÷ÀÌ·Î ±× µÚ¸¦ ÀÕ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå Á¤ÀÇ¿Í Á¶»çÀÇ ÀüÁ¦Á¶°Ç

Á¦3Àå ¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå ¿ªÇÐ

Á¦4Àå ¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå »ê¾÷ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : À¯Çüº°, 2022-2032³â

Á¦6Àå ¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Ä¡·áº°, 2022-2032³â

Á¦7Àå ¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Åõ¿© °æ·Îº°, 2022-2032³â

Á¦8Àå ¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2022-2032³â

Á¦9Àå ¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : À¯Åë ä³Îº°, 2022-2032³â

Á¦10Àå ¼¼°èÀÇ Àڱ󻸷Áõ ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø : Áö¿ªº°, 2022-2032³â

Á¦11Àå °æÀï Á¤º¸

Á¦12Àå Á¶»ç °úÁ¤

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Endometriosis Market is valued at approximately USD 1.22 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.0% over the forecast period 2024-2032. Endometriosis is a chronic medical condition where tissue similar to the lining inside the uterus, called the endometrium, grows outside the uterus. This abnormal growth can occur on the ovaries, fallopian tubes, outer surface of the uterus, and other pelvic organs. Endometriosis can cause significant pain, especially during menstrual periods, and may lead to fertility problems. The endometriosis market is undergoing significant transformation, driven by an increasing emphasis on women's health issues and the introduction of innovative treatments designed to alleviate the suffering associated with this condition. The heightened awareness among women worldwide about their condition and the increasing vocalization regarding their health issues are contributing to the market's growth, making it both highly profitable and significant.

The increasing prevalence of endometriosis has led to greater patient awareness and a shift in research and development focus towards improving treatment options. Government investments in healthcare infrastructure are further propelling the demand for drugs and diagnostic equipment for endometriosis treatment. High-priced hormone-based therapeutics dominate the market, with companies offering patient assistance programs to reduce the cost burden on patients. This approach is expected to drive patient adherence and market growth over the forecast period. However, the market faces challenges due to the lack of non-invasive diagnostic tests for endometriosis, which restrains its growth. The fear associated with non-invasive diagnostics procedures also poses a challenge, despite increasing awareness about early detection.

Key regions considered in the study include North America, Europe, Asia Pacific, Latin America, and the Rest of the World. Asia Pacific dominates the market with the presence of numerous generic manufacturers and rising disposable incomes. Asia Pacific countries present significant opportunities for the life sciences industry, with nations like India and South Korea making strides to establish themselves as major biopharmaceutical innovation hubs. The growing demand for curative treatments for life-threatening diseases emphasizes the importance of drug research and development, thereby driving the demand for related diagnostic and treatment solutions. North America holds the fastest market growth share due to its established regulatory framework, high demand for disease-specific treatment, and advanced healthcare infrastructure. Europe follows closely, driven by the presence of globally marketed players and population growth.

Major market players included in this report are:

The detailed segments and sub-segment of the market are explained below:

By Type:

By Treatment:

By Route of Administration:

By End Users:

By Distribution Channel:

By Region:

Years considered for the study are as follows:

Key Takeaways:

Table of Contents

Chapter 1. Global Endometriosis Market Executive Summary

Chapter 2. Global Endometriosis Market Definition and Research Assumptions

Chapter 3. Global Endometriosis Market Dynamics

Chapter 4. Global Endometriosis Market Industry Analysis

Chapter 5. Global Endometriosis Market Size & Forecasts by Type 2022-2032

Chapter 6. Global Endometriosis Market Size & Forecasts by Treatment 2022-2032

Chapter 7. Global Endometriosis Market Size & Forecasts by Route of Administration 2022-2032

Chapter 8. Global Endometriosis Market Size & Forecasts by End-Users 2022-2032

Chapter 9. Global Endometriosis Market Size & Forecasts by Distribution Channel 2022-2032

Chapter 10. Global Endometriosis Market Size & Forecasts by Region 2022-2032

Chapter 11. Competitive Intelligence

Chapter 12. Research Process

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â